Balyasny Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-39,836
| Closed | -$149K | – | 2118 |
|
|
2023
Q4 | $149K | Sell |
39,836
-106,316
| -73% | -$398K | ﹤0.01% | 1781 |
|
|
2023
Q3 | $310K | Sell |
146,152
-85,643
| -37% | -$182K | ﹤0.01% | 1441 |
|
|
2023
Q2 | $1.1M | Buy |
231,795
+62,939
| +37% | +$300K | ﹤0.01% | 1209 |
|
|
2023
Q1 | $962K | Buy |
+168,856
| New | +$962K | ﹤0.01% | 1352 |
|
|
2018
Q2 | – | Sell |
-13,828
| Closed | -$135K | – | 1678 |
|
|
2018
Q1 | $135K | Sell |
13,828
-28,081
| -67% | -$274K | ﹤0.01% | 1614 |
|
|
2017
Q4 | $256K | Buy |
41,909
+30,311
| +261% | +$185K | ﹤0.01% | 1560 |
|
|
2017
Q3 | $46K | Buy |
+11,598
| New | +$46K | ﹤0.01% | 1614 |
|